Cargando…

Tumor-associated neutrophils correlate with poor prognosis in diffuse large B-cell lymphoma patients

Detalles Bibliográficos
Autores principales:	Manfroi, B., Moreaux, J., Righini, C., Ghiringhelli, F., Sturm, N., Huard, B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033870/ https://www.ncbi.nlm.nih.gov/pubmed/29977076 http://dx.doi.org/10.1038/s41408-018-0099-y

Ejemplares similares

The microenvironment of DLBCL is characterized by noncanonical macrophages recruited by tumor-derived CCL5
por: Manfroi, Benoît, et al.
Publicado: (2021)

Comment on ‘Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?’
por: Liu, Yuying, et al.
Publicado: (2018)

Poor Prognosis of Diffuse Large B-Cell Lymphoma with Hepatitis C Infection
por: Tsai, Yu-Fen, et al.
Publicado: (2021)

Relapsed Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type
por: Wu, Shaohua, et al.
Publicado: (2017)

Systemic diffuse large B-cell lymphoma with bilateral ciliary body involvement
por: Di, Yu, et al.
Publicado: (2020)

Expression profile of translation initiation factor eIF2B5 in diffuse large B-cell lymphoma and its correlation to clinical outcome
por: Unterluggauer, Julia J., et al.
Publicado: (2018)

Gene expression-based risk score in diffuse large B-cell lymphoma
por: Bret, Caroline, et al.
Publicado: (2012)

An 11 years delayed diagnosis of primary pulmonary diffuse large B cell lymphoma
por: Yu, Jin-Yan, et al.
Publicado: (2019)

Neurolymphomatosis caused by diffuse large B-cell lymphoma presenting as isolated brachial plexopathy
por: Li, Heng, et al.
Publicado: (2019)

Deregulation of COMMD1 Is Associated with Poor Prognosis in Diffuse Large B-cell Lymphoma
por: Taskinen, Minna, et al.
Publicado: (2014)

Molecular characteristics of diffuse large B-cell lymphoma in the Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin lymphomas (PETAL) trial: correlation with interim PET and outcome
por: Richter, Julia, et al.
Publicado: (2019)

Prognostic impact of a past or synchronous second cancer in diffuse large B cell lymphoma
por: Tanba, Kazuna, et al.
Publicado: (2018)

Genomic complexity is associated with epigenetic regulator mutations and poor prognosis in diffuse large B-cell lymphoma
por: You, Hua, et al.
Publicado: (2021)

Tumor Microenvironment in Diffuse Large B-Cell Lymphoma: Role and Prognosis
por: Cioroianu, Alexandra Ioana, et al.
Publicado: (2019)

Phenotypic Characterization of Diffuse Large B-Cell Lymphoma Cells and Prognostic Impact
por: Devin, Julie, et al.
Publicado: (2019)

Molecular heterogeneity of CD30+ diffuse large B-cell lymphoma with prognostic significance and therapeutic implication
por: Huo, Yu-Jia, et al.
Publicado: (2022)

R-CEOP as first-line treatment for anthracycline-ineligible patients with diffuse large B-cell lymphoma
por: Al-Sarayfi, Diana, et al.
Publicado: (2022)

Proteomics uncovers molecular features for relapse risk stratification in patients with diffuse large B-cell lymphoma
por: Ludvigsen, Maja, et al.
Publicado: (2023)

Exploring tumor clonal evolution in bone marrow of patients with diffuse large B-cell lymphoma by deep IGH sequencing and its potential relevance in relapse
por: Ma, Jiao, et al.
Publicado: (2019)

Primary Small Intestinal Diffuse Large B-cell Lymphoma Masquerading as Crohn's Disease: A Case Report
por: Lu, Xiao-Hong, et al.
Publicado: (2017)

Oral CHOP‐like chemotherapy in 60–80 years‐old patients with diffuse large B‐cell lymphoma
por: Guidez, Stephanie, et al.
Publicado: (2019)

Glofitamab therapy for diffuse large B cell lymphoma: latest updates from the 2022 ASH Annual Meeting
por: Wang, Chaoyu, et al.
Publicado: (2023)

Disseminated Invasive Mucormycosis Infection Following Autologous Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma
por: Cliff, Edward R. Scheffer, et al.
Publicado: (2023)

Elevated M-MDSCs in Circulation Are Indicative of Poor Prognosis in Diffuse Large B-Cell Lymphoma Patients
por: Wang, Zhitao, et al.
Publicado: (2021)

High PTX3 expression is associated with a poor prognosis in diffuse large B‐cell lymphoma
por: Carreras, Joaquim, et al.
Publicado: (2021)

Inhibition of the STAT3 target SGK1 sensitizes diffuse large B cell lymphoma cells to AKT inhibitors
por: Lu, Li, et al.
Publicado: (2019)

Clinical and prognostic features of primary retroperitoneal diffuse large B-cell lymphoma: a single-center experience in China
por: Liu, Xiao-Hong, et al.
Publicado: (2021)

A retrospective study of MYC rearranged diffuse large B-cell lymphoma in the context of the new WHO and ICC classifications
por: El-Sharkawi, Dima, et al.
Publicado: (2023)

SKIN NODULES AS A PRESENTING FEATURE OF DIFFUSE LARGE B-CELL GASTRIC LYMPHOMA
por: Suresh Attili, V Satya, et al.
Publicado: (2008)

High TNFRSF14 and low BTLA are associated with poor prognosis in Follicular Lymphoma and in Diffuse Large B-cell Lymphoma transformation
por: Carreras, Joaquim, et al.
Publicado: (2019)

Long noncoding RNA PVT1 promotes tumor growth and predicts poor prognosis in patients with diffuse large B‐cell lymphoma
por: Yang, Ruifeng, et al.
Publicado: (2020)

Tumor-associated macrophages predict prognosis in diffuse large B-cell lymphoma and correlation with peripheral absolute monocyte count
por: Li, Yan-Li, et al.
Publicado: (2019)

Dynamic change of soluble interleukin-2 receptor distinguished molecular heterogeneity and microenvironment alterations in diffuse large B-cell lymphoma
por: Huo, Yu-Jia, et al.
Publicado: (2022)

Comparison of tisagenlecleucel with conventional treatments for relapsed/refractory diffuse large B-cell lymphomas: a retrospective external comparator study
por: Park, Sohee, et al.
Publicado: (2023)

Rapid tumor regression from PD-1 inhibition after anti-CD19 chimeric antigen receptor T-cell therapy in refractory diffuse large B-cell lymphoma
por: Hill, Brian T., et al.
Publicado: (2019)

MYC translocation and/or BCL 2 protein expression are associated with poor prognosis in diffuse large B‐cell lymphoma
por: Kawamoto, Keisuke, et al.
Publicado: (2016)

Molecular characterization of Richter syndrome identifies de novo diffuse large B-cell lymphomas with poor prognosis
por: Broséus, Julien, et al.
Publicado: (2023)

Expression of IL‐34 correlates with macrophage infiltration and prognosis of diffuse large B‐cell lymphoma
por: Noyori, Osamu, et al.
Publicado: (2019)

Nucleotide excision DNA repair pathway as a therapeutic target in patients with high-risk diffuse large B cell lymphoma
por: Bret, Caroline, et al.
Publicado: (2013)

Immune-depleted tumor microenvironment is associated with poor outcomes and BTK inhibitor resistance in mantle cell lymphoma
por: Jain, Preetesh, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_elmg5s406iqlap0vau1qe1qec9